New screening tool can identify preeclampsia risk sooner, test maker says
CNN
A new blood test can be performed in a pregnant person’s first trimester to help assess their risk of developing preeclampsia, a potentially life-threatening pregnancy complication.
A new blood test can be performed in a pregnant person’s first trimester to help assess their risk of developing preeclampsia, a potentially life-threatening pregnancy complication. It’s the first and only test of its kind available in the United States that can be used between 11 and 14 weeks gestation to determine the risk of preeclampsia before 34 weeks of pregnancy, its maker, Labcorp, announced Wednesday. The first trimester is the period from 0 to 13 weeks of a pregnancy. However, the new test doesn’t change clinical guidance on preeclampsia, according to the American College of Obstetricians and Gynecologists, also known as ACOG. Some doctors question how it will help. “It is currently unclear how useful the LabCorp test will be in accurately predicting risk for developing preeclampsia and whether it is appropriate for all pregnant patients,” Dr. Christopher Zahn, ACOG’s interim CEO and chief of clinical practice and health equity and quality, said in a statement. “Before a screening test can be successfully employed, there needs to be an evidence-based intervention to either prevent or reduce the impact of the disease. We currently have no data on how to reduce the risk for a pregnant patient predicted to have preeclampsia from a blood test early in pregnancy as opposed to clinical factors,” he added. Preeclampsia is a complication of pregnancy marked by elevated blood pressure and high levels of protein in the urine or other signs of organ damage. The condition typically develops after 20 weeks of pregnancy – in the second trimester – and if left untreated, it can turn serious or deadly for both mother and baby.
Before South African high school students complete their final exams, they first walk the red carpet, pulling out all the stops for their celebratory matriculation, or ‘matric,’ balls. The photographer Alice Mann documented the increasingly lavish dances for five years in her new book, “The Night is Young.”
The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they feel abandoned by the US Food and Drug Administration’s new stance on leucovorin.
The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when officials touted the drug as a potential treatment for thousands of children with autism.
With the release of “The Bride!” we asked scholars, film curators and experts in Mary Shelley’s work why so few women have tackled the Frankenstein story — and the impact that has on how we make sense of the 200-year-old tale.
In front of the Louvre Pyramid, Eileen Gu stepped out this week wearing a set of diaphanous wings — a fitting ensemble for an Olympic athlete whose sport sends her airborne.
Meagan Johnson recently spent four days calling dozens of pharmacies around Austin, Texas, trying to fill a prescription for her son, Jack.
Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed answers through more study.
Known for her blistering pace and powerful shots, the soccer player is having a Barbie made in her likeness as the toymaker names her as role model of the year.
The Screen Actors Guild Awards are back with a new name — and a thematic dress code.
There’s growing concern that the US Department of Health and Human Services is abandoning the US Preventive Services Task Force – or pushing it into “quiet paralysis.”
An international meeting to determine the status of measles elimination in the United States has been delayed seven months, from its original date in mid-April until sometime in November.
When she was in her 40s Jenny Teeters had a serious secret drinking problem, but, she says, her success hid it exceptionally well for years. At one point she managed a high six-figure tech job, raised two teenage girls, finished her MBA, and taught Zumba in her spare time and somehow she did it all while intoxicated.But she got to a place where she knew she needed help, and like with what a new study found, she found what finally made her sobriety stick was developing a newfound faith in a higher power.
Gucci’s new designer Demna embraces the technology, with uneven results.